Epigenetically Altered T Cells Contribute to Lupus Flares

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Lupus flares are triggered by environmental factors and drugs in genetically susceptible individuals.
• The precise mechanisms underlying these flares, particularly the role of specific immune cells, have remained largely unclear.
• Existing evidence suggested a link between certain drugs and environmental agents to immune system dysregulation.

Purpose of the Study:

• To elucidate the mechanisms by which exogenous agents trigger lupus flares.
• To identify and characterize the specific subset of CD4+ T cells involved in lupus pathogenesis.
• To explore potential therapeutic targets for treating lupus flares based on these cellular mechanisms.

Main Methods:

• Analysis of gene expression in CD4+ T cells following exposure to lupus-triggering agents.
• Identification of distinct CD4+ T cell subsets in patients with active lupus.
• Transcriptional profiling to identify unique protein expression in the identified T cell subset.

Main Results:

• Procainamide, hydralazine, and inflammation induce DNA methylation changes in CD4+ T cells, leading to autoreactivity.
• These modified CD4+ T cells were sufficient to induce lupus in mice and are present in active human lupus cases.
• A distinct CD4+ T cell subset responsible for lupus flares was identified, exhibiting unique protein expression.

Conclusions:

• Environmental agents and drugs can reprogram CD4+ T cells via DNA methylation, creating autoreactive cells that drive lupus flares.
• This distinct CD4+ T cell subset represents a promising therapeutic target for lupus flare management.
• Identifying unique proteins on these cells offers a strategy for targeted depletion and treatment of lupus flares.